The high and rather selective tumour uptake of very promising FAP-targeting tracers as described opens up applications for non-invasive tumour characterization, staging examinations, and radioligand therapy in many different cancers with a high content of activated fibroblasts. The gene discussed is FAP; the disease is cancer.